Literature DB >> 14713672

HIV prevention among injection drug users: the need for integrated models.

David S Metzger1, Helen Navaline.   

Abstract

Opportunistic infections (OIs) were first recognized among injection drug users (IDUs) in New York City in 1981. By the mid-1980s, OIs had become associated with HIV infection, and attention began to focus on efforts to prevent HIV transmission among IDUs. Since then, a range of prevention strategies has been implemented and evaluated in an attempt to reduce the spread of HIV infection among drug users. These prevention strategies include (1) HIV testing and counseling and educational and behavioral interventions delivered through community outreach; (2) condom, bleach, and needle distribution and syringe access and exchange programs; (3) substance abuse treatment; and, more recently, (4) prevention interventions targeting HIV-positive IDUs. Data from evaluations of these strategies over the past 20 years have provided substantial evidence of effectiveness and have helped to inform network-based and structural interventions. Despite the cumulative empirical evidence, however, research findings have yet to be widely disseminated, adopted, and implemented in a sustained and integrated fashion. The reasons for this are unclear, but point to a need for improved communications with program developers and community planners to facilitate the implementation and evaluation of integrated intervention strategies, and for collaborative research to help understand policy, legal, economic, and local barriers to implementation.

Entities:  

Mesh:

Year:  2003        PMID: 14713672      PMCID: PMC3456261          DOI: 10.1093/jurban/jtg083

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  42 in total

1.  The effect of a needle exchange program on numbers of discarded needles: a 2-year follow-up.

Authors:  M C Doherty; B Junge; P Rathouz; R S Garfein; E Riley; D Vlahov
Journal:  Am J Public Health       Date:  2000-06       Impact factor: 9.308

2.  Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors.

Authors:  H Hagan; J P McGough; H Thiede; S Hopkins; J Duchin; E R Alexander
Journal:  J Subst Abuse Treat       Date:  2000-10

3.  Access to medical care and service utilization among injection drug users with HIV/AIDS.

Authors:  A R Knowlton; D R Hoover; S E Chung; D D Celentano; D Vlahov; C A Latkin
Journal:  Drug Alcohol Depend       Date:  2001-09-01       Impact factor: 4.492

Review 4.  Needle exchange programs for the prevention of human immunodeficiency virus infection: epidemiology and policy.

Authors:  D Vlahov; D C Des Jarlais; E Goosby; P C Hollinger; P G Lurie; M D Shriver; S A Strathdee
Journal:  Am J Epidemiol       Date:  2001-12-15       Impact factor: 4.897

5.  HIV-1 RNA viral load monitoring in HIV-infected drug users on antiretroviral therapy: relationship with outpatient care patterns.

Authors:  Christine Laine; Daozhi Zhang; Walter W Hauck; Barbara J Turner
Journal:  J Acquir Immune Defic Syndr       Date:  2002-03-01       Impact factor: 3.731

6.  The relationship of counseling and self-help participation to patient outcomes in DATOS.

Authors:  R M Etheridge; S G Craddock; R L Hubbard; J L Rounds-Bryant
Journal:  Drug Alcohol Depend       Date:  1999-12-01       Impact factor: 4.492

7.  Physician prescribing of sterile injection equipment to prevent HIV infection: time for action.

Authors:  S Burris; P Lurie; D Abrahamson; J D Rich
Journal:  Ann Intern Med       Date:  2000-08-01       Impact factor: 25.391

8.  Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area.

Authors:  H Thiede; H Hagan; C S Murrill
Journal:  J Urban Health       Date:  2000-09       Impact factor: 3.671

Review 9.  Syringe availability as HIV prevention: a review of modalities.

Authors:  P Coffin
Journal:  J Urban Health       Date:  2000-09       Impact factor: 3.671

10.  Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users.

Authors:  D D Celentano; N Galai; A K Sethi; N G Shah; S A Strathdee; D Vlahov; J E Gallant
Journal:  AIDS       Date:  2001-09-07       Impact factor: 4.177

View more
  23 in total

1.  Barriers to providing health services for HIV/AIDS, hepatitis C virus infection and sexually transmitted infections in substance abuse treatment programs in the United States.

Authors:  Edmund J Bini; Steven Kritz; Lawrence S Brown; Jim Robinson; Don Alderson; John Rotrosen
Journal:  J Addict Dis       Date:  2011-04

Review 2.  Toward a comprehensive approach to HIV prevention for people who use drugs.

Authors:  Brandon D L Marshall; Evan Wood
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

Review 3.  Drug treatment as HIV prevention: a research update.

Authors:  David S Metzger; George E Woody; Charles P O'Brien
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

4.  Willingness to use HIV pre-exposure prophylaxis among opiate users.

Authors:  Michael Stein; Portia Thurmond; Genie Bailey
Journal:  AIDS Behav       Date:  2014-09

5.  The Global HIV Archive: Facilitating the Transition from Science to Practice of Efficacious HIV Prevention Interventions.

Authors:  Josefina J Card; Emily N Newman; Rachel E Golden; Tamara Kuhn; Carmela Lomonaco
Journal:  World J AIDS       Date:  2013-03

6.  Preexposure prophylaxis for adolescents and young adults at risk for HIV infection: is an ounce of prevention worth a pound of cure?

Authors:  Jill E Pace; George K Siberry; Rohan Hazra; Bill G Kapogiannis
Journal:  Clin Infect Dis       Date:  2012-12-07       Impact factor: 9.079

7.  HIV seroconversion and risk factors among drug users receiving methadone maintenance treatment in China: A qualitative study.

Authors:  Changhe Wang; Cynthia X Shi; Bo Zhang; Hong Chen; Hua Wang; Nanci Zhang; Keming Rou; Xiaobin Cao; Wei Luo; Zunyou Wu
Journal:  Drug Alcohol Depend       Date:  2016-08-21       Impact factor: 4.492

8.  Epidemiology of HIV among injecting and non-injecting drug users: current trends and implications for interventions.

Authors:  Steffanie A Strathdee; Jamila K Stockman
Journal:  Curr HIV/AIDS Rep       Date:  2010-05       Impact factor: 5.071

9.  A latent class approach to treatment readiness corresponds to a transtheoretical ("Stages of Change") model.

Authors:  Paul Truman Harrell; R C Trenz; M Scherer; S S Martins; W W Latimer
Journal:  J Subst Abuse Treat       Date:  2013-05-22

10.  Factors associated with interest in receiving prison-based methadone maintenance therapy in Malaysia.

Authors:  Trena I Mukherjee; Jeffrey A Wickersham; Mayur M Desai; Veena Pillai; Adeeba Kamarulzaman; Frederick L Altice
Journal:  Drug Alcohol Depend       Date:  2016-05-09       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.